- Presentations
- 6
- Markets
- 1
Amjevita is a brand of Adalimumab marketed by Amgen, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Adalimumab
- Brand owner
- Amgen
- Registered in
- United States
- Strengths and forms
- 10 mg/0.2 mL injection, 20 mg/0.2 mL injection, 20 mg/0.4 mL injection, 40 mg/0.4 mL injection, 40 mg/0.8 mL injection, 80 mg/0.8 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Amjevita 10 mg/0.2 mL injectionSubcutaneous Cold chain | Amgen | US FDA | Available on request |
| Amjevita 20 mg/0.2 mL injectionSubcutaneous Cold chain | Amgen | US FDA | Available on request |
| Amjevita 20 mg/0.4 mL injectionSubcutaneous Cold chain | Amgen | US FDA | Available on request |
| Amjevita 40 mg/0.4 mL injectionSubcutaneous Cold chain | Amgen | US FDA | Available on request |
| Amjevita 40 mg/0.8 mL injectionSubcutaneous Cold chain | Amgen | US FDA | Available on request |
| Amjevita 80 mg/0.8 mL injectionSubcutaneous Cold chain | Amgen | US FDA | Available on request |
Equivalent brands
Other brands of Adalimumab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Amjevita
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.